Promoting the Quality of Medicines Plus (PQM+) Program

The Promoting the Quality of Medicines Plus (PQM+) program improves access to quality-assured priority medicines and addresses the proliferation of poor-quality medical products in low- and middle-income countries. Funded by the U.S. Agency for International Development, PQM+ strengthens medical product quality assurance systems in low- and middle-income countries through cross-sectoral and systems strengthening approaches and the application of international quality assurance standards across the pharmaceutical system. By sharing scientific expertise and providing technical support and leadership, PQM+ helps create resilient and robust local health systems that address diseases like HIV/AIDS, tuberculosis, malaria and neglected tropical diseases, as well as improves maternal, newborn and child health.

For the latest on the PQM+ program subscribe to our newsletter: Subscribe now  Latest issue

Chlorhexidine digluconate
Guidance on development, manufacture of Chlorhexidine digluconate (7.1%) gel

Learn how to develop and manufacture quality-assured chlorhexidine digluconate (7.1%) gel for umbilical cord care in the GSK Technology Transfer Report.


Good Manufacturing Practices (GMP) course
Foundations of Good Manufacturing Practices: free online course

Covering the essentials of Good Manufacturing Practices (GMP), which help to ensure the quality of medical products.

Learn more and enroll